Purchase Order 75N91024P00669
- Not listed
- This is a firm fixed price purchase order valued at $22,400.00 awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Twist Bioscience Corporation for DNA synthesis services to support gene cloning. The contract has no set-aside designation and the ultimate completion date is December 31, 2024. Twist Bioscience is a synthetic biology company that specializes in manufacturing high-quality synthetic DNA and has...
- This is a firm fixed price purchase order contract awarded by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH), to Twist Bioscience Corporation, a for-profit synthetic biology company based in South San Francisco, California. The contract is for the provision of biological and reagent materials, with a ceiling value of $12,206.25 and a period of performance through September 4, 2025. There is no set-aside designation for this...
- Twist Bioscience Corporation has been awarded a firm fixed price purchase order contract valued at $24,285 by the National Institutes of Health's National Institute of Neurological Disorders and Stroke to provide a custom single site variant library. As the prime contractor, Twist Bioscience will deliver the requested synthetic DNA products to support genomics research efforts. No set aside designation was applied to this award. Twist Bioscience is a manufacturer of synthetic DNA based in...
- This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Twist Bioscience Corporation, a synthetic biology company based in South San Francisco, California. The $97,588 contract is for the provision of COVID-19 DNA constructs, which likely support genomics research, disease surveillance, and public health initiatives. This contract does not have a set-aside designation. Twist...
- This is a $14,031.25 firm fixed price purchase order awarded by the National Human Genome Research Institute (NHGRI) to Twist Bioscience Corporation, a synthetic biology company based in South San Francisco, California. The contract is for Twist Bioscience to provide a custom capture panel to support a new blood-based cancer diagnostic that will detect human herpesvirus 8 (HHV8) in the plasma of HIV patients. The award has an ultimate completion date of October 31, 2024 and was made on August...
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a firm fixed price purchase order valued at $15,117.00 to Twist Bioscience Corporation, a synthetic biology company based in South San Francisco, California. The contract is for the delivery of a TWIST Library Preparation Kit 1. This award does not have a set-aside designation. Twist Bioscience is a prime contractor on this purchase order, which has an ultimate completion date of October 14, 2024. The company...
- The Department of Health and Human Services' National Institutes of Health National Institute on Aging awarded a $77,874 purchase order to Twist Bioscience Corporation of South San Francisco, California. Under the firm fixed price contract, Twist Bioscience will provide custom cloned pooled oligo libraries in support of the NIH NIA's biomedical research efforts. The contract runs from July 10, 2023 through August 31, 2023 and represents a small purchase awarded directly to the prime contractor...
- <p>The National Human Genome Research Institute awarded a purchase order to Twist Bioscience Corporation valued at $24,465.50 on September 4, 2020, for synthetic biology and DNA synthesis products. Performance is at Twist Bioscience's facility in South San Francisco, California, with a completion date of November 30, 2020. The order carries firm fixed-price pricing with no small business set-aside.</p>
- This federal contract award to Twist Bioscience Corporation, a synthetic biology company in South San Francisco, CA, is for the delivery of COVID-19 DNA constructs. The $29,671.85 firm fixed price purchase order was awarded on June 4, 2020 by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the National Institutes of Health (NIH). The contract does not have a set-aside designation. Through this award, as well as previous contracts and grants, Twist...
- The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a firm fixed price purchase order to Twist Bioscience Corporation, a for-profit synthetic biology company, to provide TWIST RNA products for the FLUSC2 MULTIPLE program. The $51,160.00 contract does not have a set-aside designation and is scheduled for completion by April 30, 2024. Twist Bioscience, a manufacturer of goods, has previously received numerous federal contracts to supply synthetic...
This is a firm fixed price purchase order contract awarded by the National Cancer Institute (NCI), a civilian agency under the National Institutes of Health (NIH), to Twist Bioscience Corporation. The $21,578.25 contract is for the delivery of oligonucleotide pools needed for a gene expression/MPRA (Massively Parallel Reporter Assay) research project. The contract has no set-aside designation and is scheduled for completion by September 30, 2024. Twist Bioscience is a synthetic biology company that has been awarded numerous federal contracts and grants to provide custom oligonucleotides, gene panels, and other genomics-related products and services to support research initiatives at agencies such as the NIH, CDC, VA, and Department of the Air Force. This contract aligns with the NCI's mission to conduct and support cancer research, including through the development of advanced genomic and molecular technologies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $21.6k | 8/23/24 |